ArticleBMC medicine2026

Targeting STE20-type kinase MST3 improves metabolic dysfunction-associated steatohepatitis without affecting hepatocellular carcinoma development in mice.

Jingjing Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.